UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 23, 2005
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 000-32085 | 36-4392754 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
222 Merchandise Mart, Suite 2024
Chicago, IL 60654
Registrant’s telephone number, including area code 1-800-654-0889.
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| ITEM 7.01. | Regulation FD Disclosure. |
Attached as Exhibit 99.1 hereto is an updated Investor Presentation dated November 2005, which is incorporated herein by reference. The Investor Presentation has been updated to include information on Allscripts Healthcare Solutions, Inc.’s $200 million shelf registration filed on November 18, 2005.
This information is being furnished pursuant to Item 9 of this Report and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section and will not be incorporated by reference into any registration statement filed by Allscripts Healthcare Solutions, Inc. under the Securities Act of 1933, as amended, unless specifically identified as being incorporated therein by reference. This Report will not be deemed an admission as to the materiality of any information in this Report that is being disclosed pursuant to Regulation FD.
Please refer to page 2 of Exhibit 99.1 for a discussion of certain forward-looking statements included therein and the risks and uncertainties related thereto.
| ITEM 9.01. | Financial Statements, Pro Forma Financial Information and Exhibits. |
| (c) | Exhibits: |
| 99.1 | Investor Presentation dated November 2005 | |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. | ||||||||
| Date: November 23, 2005 | By: | /S/ WILLIAM J. DAVIS | ||||||
| William J. Davis Chief Financial Officer | ||||||||
3
EXHIBIT INDEX
The following exhibit is filed herewith:
| Exhibit No. |
||
| 99.1 | Investor Presentation dated November 2005. | |
 Page 1 November 2005 Exhibit 99.1 |
 Page 2 This presentation may contain forward-looking statements about Allscripts Healthcare Solutions that involve risks and uncertainties. These statements are developed by combining currently available information with Allscripts’ beliefs and assumptions. Forward-looking statements do not guarantee future performance. Because Allscripts cannot predict all of the risks and uncertainties that may affect it, or control the ones it does predict, Allscripts’ actual results may be materially different from the results expressed in its forward-looking statements. For a more complete discussion of the risks, uncertainties and assumptions that may affect Allscripts, see the Company’s 2004 Annual Report on Form 10-K, available at www.sec.gov. Safe Harbor |
 Page 3 We Provide Clinical Software, Connectivity & Information Solutions To Physicians 360 Employees Public (Nasdaq: MDRX) Financial Strength - $135+ Million in Cash Reserves - $100+ Million in 2004 Revenue - Diversified/Multiple Revenue Streams - The Leader in High Growth Markets Culture - Fast Moving, Client-Focused and Innovative What We Do & Who We Are . . . |
 Page 4 Our Vision Why? Physicians Control 80% of a $1.7 Trillion Annual Spend To Become an Indispensable Part of the Way Physicians Practice Medicine |
 Page 5 How To Become Indispensable for Physicians? …By Delivering Solutions That Inform, Connect and Transform Healthcare |
 Page 6 A Different Perspective… Traditional View Hospital Our View Healthcare Revolves Around the Physician |
 Page 7 Delivering Value Through Our Solutions E-Detailing Medication Dispensing Document Imaging E-Prescribing Electronic Health Record Personal Health Record Adherence/ Compliance |
 Page 8 What Our Products Actually Do . . . Reach 20,000 MDs with Drug Recall Information The Ability to Educate 10,000 MDs by Tomorrow Morning Decisions Based on Real-Time Evidence-Based Data Health vs. Healthcare With Physician Directed Information Inform-Connect-Transform Making the Impossible Possible |
 Page 9 An EMR Informs You |
 Page 10 An EHR Connects You |
 Page 11 The Opportunity EHR Market Electronic Health Record Market $6 Billion Market Tools & Technology are Better, Less Expensive Physicians Willingness to Adopt Technology Proven, Measurable ROI |
 Page 12 The Allscripts Advantage EHR Market Blue-Chip Client Base Modular Approach Proven Process for Rapid Implementation Leadership in National Initiatives Top Rated in Every Industry Evaluation With IDX Partnership, Preferred Access to 70% of Large Groups |
 Page 13 Market Share EHR Market - Segmentation Market Segment > 25 Physicians 10 to 24 Physicians < 10 Physicians Specialties Status Leader Competitive Evolving Leader 12 Month Management Objective: Profitable Leadership In Each Segment
(Buy, Build or Partner) |
 Page 14 Over 1,500 Leading Clinics Across the U.S. Market Share EHR Market - Client Base |
 Page 15 Market Share EHR Market - Client Base Academic Medical Groups Specialty Groups Multi-Specialty Groups Integrated Delivery Networks Over 1,500 Leading Clinics Across the U.S. |
 Page 16 If Doctors Don’t Use It Nothing Else Matters Utilization EHR Market IDDUINEM |
 Page 17 Utilization EHR Market “The EHR That Pays You Back” Clinical Trials - Holston Medical Group: Generates $3M/Yr. in Clinical Trial Revenue Pay for Performance - Facey Medical: Receives $1.2M P4P Payout from Blue Cross E-Prescribing - Sierra Health: Achieves $5M in Savings via eRx Medical Records - George Washington Univ. Medical Faculty Assoc.: Reduction of 20 FTEs in Medical Records Transcription/Documentation - Central Utah Clinic: Independently Documents $1M in Savings in First Year ($20K/MD) Charges - University of Tennessee Medical Group: Increases Avg. Gross Charges by > $30/Patient Visit |
 Page 18 Leadership |
 Page 19 We “Wrote the Book” Leadership |
 Page 20 The Opportunity Physicians Interactive MD/Patient Education Market Pharma Industry Marketing Spend = $15 Billion/Year Current Market for Online Product Education ~$250mm 43% of Pharma Detail Calls End at Receptionist 50% of Detail Calls Last < 2 Minutes |
 Page 21 The Allscripts Advantage Physicians Interactive Blue-Chip Client Base Portfolio of Solutions Leadership in Adherence/ Compliance Proven Return-On-Investment |
 Page 22 Market Share Physicians Interactive Blue-Chip Client Base 39 Pharmaceutical, Biotech & Medical Device Companies 8 of Top 10 Pharmaceutical Companies More Programs Delivered 400 Programs for 100 Brands 59 International Programs in 8 Countries Significant Traction with Physicians 85,000 Unique Physician Participants in U.S. > 300,000 Educational Sessions Completed |
 Page 23 Key Takeaways 1. The Time is Now 2. Our Physician Focus = Key to Transforming Healthcare 3. We are the Leader in Growth Markets We Compete In 4. Competitive Advantage = Driving Utilization and Results We’re Just Getting Started |
 Page 24 Historical/Forecast Revenue ($ in Millions) $0 $20 $40 $60 $80 $100 $120 $140 2002 2003 2004 2005 (E) Clinical Solutions and Information Services Medications 37% 63% 63% 56% 46% 54% 44% 37% |
 Page 25 Historical/Forecast EPS $0.22 to $0.24 $0.07 ($0.13) ($0.40) ($0.50) ($0.40) ($0.30) ($0.20) ($0.10) $0.00 $0.10 $0.20 $0.30 2002 2003 2004 2005 (E) |
 Page 26 Clinical Solutions Bookings ($ in Millions) $0 $10 $20 $30 $40 $50 $60 $70 $80 2002 2003 2004 2005 (E) 58% Growth 74% Growth 40%+ Growth |
 Page 27 Physicians Interactive Bookings ($ in Millions) $0 $2 $4 $6 $8 $10 $12 $14 $16 $18 2003 2004 2005 (E) 32% Growth 5% Growth |
 Page 28 Backlog ($ in Millions) 32% growth 48% growth 31% growth $0 $10 $20 $30 $40 $50 $60 $70 $80 $90 $100 2002 2003 2004 2005 (E) Clinical Solutions Physicians Interactive |
 Page 29 $8.7 $12.7 $13.4 $44.1 $0 $10 $20 $30 $40 $50 $60 $70 $80 CSG Maintainance/Supp ort PI CSG Subscriptions CSG License/Implement ation Fees Financial Overview: Backlog as of September 30 ,2005 (in millions) $78.9 Million $78.9 Million |
 Page 30 Financial Overview: Financial Position as of September 30, 2005 (in millions) Cash & Marketable Securities $136.1 Accounts Receivable, Net 26.8 Other Assets 45.0 Total Assets $207.9 Accounts Payable & Accrued Liabilities $16.0 Deferred Revenue 15.1 Convertible Debt 82.5 Other Liabilities 0.4 Total Liabilities 114.0 Stockholders' Equity 93.9 Total Liabilities & Stockholders' Equity $207.9 |
 Page 31 $200 Million Shelf Registration Allscripts is evaluating a variety of M&A opportunities, which might be pursued in the near term or long term Allscripts wants to be prepared to move quickly should a strategic opportunity arise M&A activity is focused on: Market share (i.e., competitors) Specialties (i.e., oncology, orthopedics, cardiology, ophthalmology, etc.) Complementary product offerings Allscripts is principally focused on transactions that would be accretive to our earnings It is possible that we may consider a strategic transaction that could be dilutive to our earnings in the near term |
 Page 32 Well Positioned for Growth and Sustained Profitability Summary Continued Increase In Gross Margin Strong Financial Position Leadership Position in All Businesses Strong Sales Momentum in Growing Markets Competitive Advantage in All Markets People Physician-Centric |
 |